Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2200

Food allergy biotech Alladapt closes after Phase 3 talks with FDA

$
0
0
Alladapt Immunotherapeutics, a well-financed biotech working in the food allergy field, shut down following talks with the FDA, according to a source familiar with the company. After claiming success in a ...

Viewing all articles
Browse latest Browse all 2200

Trending Articles